In addition to animal studies, studies in obese patients have shown that serum Nrg-4 levels are inversely associated with the risk of metabolic syndrome, suggesting that Nrg-4 concentrations may be a protective factor for the development of metabolic syndrome [30]. The gene discussed is NRG4; the disease is metabolic syndrome.